People who do not suffer from any disability often take for granted the ability to freely move limbs. However, the loss of such an ability is devastating, and those to whom it happens to find life is never the same again. At least, that is the case without treatment. The good news is, paralysis may have the hope of treatment after all, in the form of stem cells. [Read more…]
Ronawk Brings On Dr. David S. Zamierowski As New Member of the Board of Directors
March 10, 2023, Olathe, KS – Ronawk, a biotech and biofabrication company powered by the Bio-Block UniverseTM, is pleased to announce the appointment of Dr. David S. Zamierowski to its Board of Directors. Dr. Zamierowski has a storied career as both a Plastic Surgeon and Inventor. He has developed countless advancements in many areas of life science. [Read more…]
Center for Breakthrough Medicines, Nucleus Biologics, and Stoic Bio Announce Strategic Collaboration for Steady Supply of Quality Controlled Cell Culture Media to Expedite Development of Cell and Gene Therapies
March 7, 2023, SAN DIEGO, CA — In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a provider of sustainable technology for cell media manufacturing, have announced plans for a supply agreement with the Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization (CDMO), whose mission is to save lives by accelerating the development and manufacture of advanced therapies. This agreement makes Nucleus Biologics the preferred supplier of cell culture media and other critical biological solutions for CBM; thus, ensuring a steady, consistent supply of this critical material with tighter quality control measures. [Read more…]
Cellular Engineering Technologies Receives Exclusivity to Use John Paul II Medical Research Institute’s Immortalized Human Stem Cells for Commercial Bio-Production Applications
The exclusive right grants Cellular Engineering Technologies the intellectual property to develop, manufacture and commercialize next generation bio-production of recombinant proteins, viral vectors for gene therapy and vaccines with a more native human post-translational modification (PTM).
iPSirius Granted Second American Patent for Innovative IPVAC Cancer Vaccine Technology
Paris, March 7 2023 – iPSirius, a leading biotechnology company focused on the development of innovative immunotherapies, announced that it has been granted its second American patent for a novel technology that enables the production of ‘off-the-shelf’ cancer vaccines from induced pluripotent stem cells (iPSCs). [Read more…]
- « Previous Page
- 1
- …
- 128
- 129
- 130
- 131
- 132
- …
- 338
- Next Page »